Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dense gemcitabine + epirubicin + paclitaxel (GET) in advanced breast cancer
2005-003582-16Phase 2Terminated
- Sponsor
- AOU Policlinico di Modena
- Start
- Apr 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of gemcitabine, epirubicin and paclitaxel in breast cancer, sponsored by AOU Policlinico di Modena. Started Apr 2007; status: terminated.
02
Drugs
gemcitabineepirubicinpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-003582-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003582-16.